Genomic regions associated with multiple sclerosis are active in B cells.
More than 50 genomic regions have now been shown to influence the risk of multiple sclerosis (MS). However, the mechanisms of action, and the cell types in which these associated variants act at the molecular level remain largely unknown. This is especially true for associated regions containing no...
Guardado en:
Autores principales: | Giulio Disanto, Geir Kjetil Sandve, Antonio J Berlanga-Taylor, Julia M Morahan, Ruth Dobson, Gavin Giovannoni, Sreeram V Ramagopalan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/541fa2c204794509a8299aba3a99f8e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuroprotection in a novel mouse model of multiple sclerosis.
por: Katie Lidster, et al.
Publicado: (2013) -
Measuring treatment response to advance precision medicine for multiple sclerosis
por: Peter A. Calabresi, et al.
Publicado: (2021) -
OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
por: E. P. Evdoshenko, et al.
Publicado: (2014) -
Differential expression profile of gluten-specific T cells identified by single-cell RNA-seq.
por: Ying Yao, et al.
Publicado: (2021) -
Pregnancy-induced effects on memory B-cell development in multiple sclerosis
por: Malou Janssen, et al.
Publicado: (2021)